BioResearch
Vaccine for Papilloma Virus Shows Promise
A phase II trial of a new vaccine candidate for patients with human papilloma virus (HPV)-related disease has shown partial clinical and/or histologic responses, associated in some cases with viral clearance, in five of 15 patients treated with a high dose of the vaccine. More...26 Mar 2004
Highly Mutated Oncogene Linked to Five Types of Cancer
Cancer researchers have found that mutations in the PIK3CA lipid kinase gene are characteristic of certain types of cancers and pre-cancerous tissues, a finding that may lead to the development of new diagnostic tests and therapeutic approaches centered on this gene. More...24 Mar 2004
In Other News
Protein Interactions Regulate Smooth Muscle Development
Cell Membrane Transport Proteins Identified
Valproic Acid May Treat Spinal Muscular Atrophy
Agent Helps Nerves Grow in Damaged Spinal Cords
Excessive Triplet Repeats Stall DNA Replication
Streamlined Preparation of Cells for Cloning
DNA Vaccine Against Anthrax
Genzyme to Acquire Ilex Oncology for $1 Billion
Aurora B Regulates Chromosome Dispersal During Cell Division
Inactivation of CBP Gene Causes Lymphoma in Mouse Model
First Angiogenesis Inhibitor Approved
Oligonucleotides Block Small RNA Function
Breast Cancer Growth Regulator Found
Procalcitonin Test Helps to Rationalize Antibiotic Use
Personal DNA Identity Cards
Electromagnetic Fields Pose Biohazard Risks
Genencor to Commercialize Decontamination Technology
BioSquare Conference to Be Held in Basel
Two-Pronged Approach Enhances Nerve Cell Regeneration
Some Recovery Forecast for Drug Discovery Market
New Strain of Mad Cow Disease Found
Millipore Awarded CE Mark
Activation of Transcription Factors in Inflammatory Diseases
BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.







